Perhaps read the last Her-vaxx trial ann. The IDMC (very expert, and FDA relevant decision makers) recommended stopping the trial early due it being unethical to continue trial patients on the current SoC - Her-vaxx was roughly twice as good in terms of OS, in a statistically significant way.
On top of an amazing safety profile.
IMHO, this is a hugely positive indication in any cancer trial, and for IMU.
The data seems to be in, what deal can be done with it?
Perhaps read the last Her-vaxx trial ann. The IDMC (very expert,...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $505.0M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.8¢ | $1.427M | 20.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 57517 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 667419 | 9 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.000 ( 0.29 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 7.1¢ | 6.8¢ | 7149293 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| IMU (ASX) Chart |